Kansas City,
30
December
2020
|
10:00 AM
America/Chicago

Healio: Transgender women outpace cisgender women in athletic tests after 1 year on hormones

By Michael Monostra

Pretreatment differences in athletic performance for transgender women in the U.S. Air Force vs. cisgender women continue more than 1 year after starting feminizing therapy, according to findings published in the British Journal of Sports Medicine.

“Transgender women retain an advantage in upper body strength (push-ups and sit-ups) over female controls for 1 to 2 years after starting gender-affirming hormones,” Timothy Roberts, MD, MPH, in the division of adolescent medicine at Children's Mercy Kansas City, Missouri, told Healio. “Transgender women retain an advantage in endurance (1.5-mile run) over female controls for over 2 years after starting gender-affirming hormones. Athletic performance among transgender men matches or exceeds athletic performance for male controls after 1 year on testosterone.”

Roberts and colleagues conducted a retrospective review of medical records and fitness tests for transgender men and women who filed a request to begin gender transition or continue testosterone or estrogen while serving in the U.S. Air Force.

“We need longer-term studies of the effect of testosterone suppression on athletic performance overall and in sport-specific activities (explosive strength, endurance and cardiovascular fitness) to inform guidelines for transgender inclusion in sport,” Roberts said.

 

Read the full study via Healio

Learn more about Research at Children's Mercy